To hear about similar clinical trials, please enter your email below
Trial Title:
A Cohort Establishment Study of Total Management of Ovarian Cancer
NCT ID:
NCT06018935
Condition:
Tumor of Female Reproductive System
Ovarian Cancer
Conditions: Official terms:
Ovarian Neoplasms
Carcinoma, Ovarian Epithelial
Genital Neoplasms, Female
Conditions: Keywords:
Ovarian cancer
Cohort study
Whole-process management
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Other
Intervention name:
No intervention
Description:
No intervention
Summary:
A cohort establishment study of total management of ovarian cancer (including fallopian
tube cancer and primary peritoneal cancer).
Detailed description:
1. To investigate the effects of surgery, chemotherapy, maintenance therapy and related
factors on the prognosis and quality of life of patients with ovarian cancer
(including fallopian tube cancer and primary peritoneal cancer);
2. To study the postoperative recovery of patients with ovarian cancer (including
fallopian tube cancer and primary peritoneal cancer), perioperative complications,
adverse reactions after chemotherapy, adverse reactions during targeted drug
maintenance therapy, and explore possible effective preventive measures;
3. The prognostic factors of ovarian cancer (including fallopian tube cancer and
primary peritoneal cancer) were analyzed;
4. To study the efficacy and safety of PARPi in clinical application in patients with
ovarian cancer (including fallopian tube cancer and primary peritoneal cancer).
Criteria for eligibility:
Study pop:
Patients diagnosed with ovarian cancer (including fallopian tube cancer, primary
peritoneal cancer) and intended to be treated in our hospital
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
1. Patients diagnosed with ovarian cancer (including fallopian tube cancer, primary
peritoneal cancer) and intended to be treated in our hospital;
2. Can cooperate with later follow-up.
Exclusion Criteria:
1. Patients with other malignant tumors or previous history of other malignant tumors;
2. Have cognitive impairment.
Gender:
Female
Minimum age:
N/A
Maximum age:
N/A
Healthy volunteers:
Accepts Healthy Volunteers
Locations:
Facility:
Name:
Sichuan Cancer Hospital
Address:
City:
Chengdu
Country:
China
Status:
Recruiting
Contact:
Last name:
Wang Dengfeng, Doctor
Phone:
15982222707
Email:
wonderful_96@163.com
Start date:
June 17, 2024
Completion date:
September 1, 2025
Lead sponsor:
Agency:
Sichuan Cancer Hospital and Research Institute
Agency class:
Other
Source:
Sichuan Cancer Hospital and Research Institute
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06018935
